Blog
RSS FeedPosted by Michael Wonder on 01 Mar 2023
Lilly cuts insulin prices by 70% and caps patient insulin out of pocket costs at $35 per month
1 March 2023 - Eli Lilly today announced price reductions of 70% for its most commonly prescribed insulins and an expansion ...
Posted by Michael Wonder on 28 Feb 2023
Drugs likely subject to Medicare negotiation (2026-2028)
28 February 2023 - In 2026-2028, we estimate that Medicare will negotiate prices for 38 Medicare Part D drugs and 2 ...
Posted by Michael Wonder on 24 Feb 2023
Member of Canada’s drug pricing regulator quits over ‘lack of support’ for medicine cost reforms
23 February 2023 - A member of the Patented Medicine Prices Review Board, Canada’s drug pricing regulator, has resigned over ...
Posted by Michael Wonder on 21 Feb 2023
$130,000 a year for medicine is outrageous. But I blame the Government, not drug makers.
21 February 2023 - I don't blame President Biden for pursuing price controls. They are popular. Yet popularity does not ...
Posted by Michael Wonder on 20 Feb 2023
‘Caught in the middle’: A battle between Vertex and insurers is leaving cystic fibrosis patients with crushing drug costs
20 February 2023 - Dan Brickey was stunned when he learned the news. ...
Posted by Michael Wonder on 20 Feb 2023
US to select 10 costliest drugs for Medicare pricing negotiation
18 February 2023 - The US Government will select the 10 costliest prescription medicines to Medicare for negotiating prices with ...
Posted by Michael Wonder on 17 Feb 2023
High drug prices are not justified by industry’s spending on research and development
15 February 2023 - Aris Angelis and colleagues argue that by refocusing their spending drug companies could provide more innovative ...
Posted by Michael Wonder on 16 Feb 2023
Testing a hypothesis: can we promote both innovation and affordability of drugs?
16 February 2023 - This week’s announcement by the CMS to test new payment models which promote both pharmaceutical access and ...
Posted by Michael Wonder on 15 Feb 2023
Germany proposes to fix shortages in certain medicines
15 February 2023 - Germany's health ministry on Tuesday vowed to fix shortages in medicines for children, antibiotics and cancer ...
Posted by Michael Wonder on 15 Feb 2023
The PBM Transparency Act will not lower drug prices
15 February 2023 - While members of Congress agree on the need to try to rein in the prices of prescription ...
Posted by Michael Wonder on 14 Feb 2023
HHS Secretary responds to the President’s Executive Order on drug prices
14 February 2023 - Action announces new models and supports access to $2 generic drugs. ...
Posted by Michael Wonder on 14 Feb 2023
Who helps keep drug costs affordable? Pharmacy benefit managers.
14 February 2023 - You may have noticed an inordinate number of television commercials offering opinions on the price of prescription ...
Posted by Michael Wonder on 13 Feb 2023
Amgen pricing for its Humira biosimilar may benefit PBMs and insurers more than patients
31 January 2023 - Underscoring the opaque and confusing nature of pharmaceutical pricing, Amgen announced long-awaited discounts for its biosimilar ...
Posted by Michael Wonder on 11 Feb 2023
State of the Union highlights America’s awkward conversation on financing the development of new medicines
9 February 2023 - Science, medicine, health care, and paying for medicines featured prominently in President Joe Biden’s State of ...
Posted by Michael Wonder on 10 Feb 2023
HHS releases initial guidance for Medicare prescription drug inflation rebate program
9 February 2023 - Under President Biden’s prescription drug law, drug companies will pay rebates to the federal government for ...